Takeover hostilities resume between Depomed and Horizon
August 10, 2015Sales and Marketing Depomed, horizon, hostile bid, nucynta, takeover, tapentadol
The bitter takeover row between Horizon and Depomed has escalated after Depomed dismissed its suitor’s latest advances, and warned it …
Price tags on medicine packs a “headline grabbing gimmick”
August 7, 2015Manufacturing and Production, Medical Communications Drug pricing, Jeremy Hunt, NHS, adherence, compliance
Plans to include a price tag on prescription medicines in England worth more than £20 have been dismissed as a …
Pharma companies ‘using more in-house digital teams’
August 7, 2015Medical Communications Med Comms, advertising, agencies, branding, communications, medical communications, social media
Fewer pharma companies are moving away from using external agencies for their digital marketing, a US survey has found.A study …
First Apple ResearchKit app launches in the UK
August 7, 2015Medical Communications Apple, clinical trial, heart disease, researchkit, strokes
The first ResearchKit app to be made available to users outside of the US has launched in the UK. The …
Bedrock Healthcare Communications makes new hires
August 6, 2015Medical Communications Bedrock Healthcare Communications
Bedrock Healthcare Communications has made several new additions to the team.Sam Simpson joins as account director, Francesca Worthington as account …
Pfizer and Flynn rapped for overcharging on anti-epilepsy drug
August 6, 2015Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing
Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …
MedImmune and Mirati to partner on lung cancer combo
August 6, 2015Research and Development AstraZeneca, Cancer, MedImmune, Mirati, Mirati Therapeutics, NSCLC, durvalumab, immuno-oncology, immunotherapy, lung cancer, mocetinostat
MedImmune is entering into an exclusive clinical trial collaboration with US-based Mirati Therapeutics to test a novel immuno-oncology combination in …
AstraZeneca buys rights to Heptares experimental cancer treatment
August 6, 2015Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, HTL-1071, immuno-oncology
AstraZeneca has entered into a licensing agreement with Heptares for the global rights to the experimental cancer treatment HTL-1071. The …
NICE demands more evidence of Lynparza benefits
August 6, 2015Sales and Marketing AstraZeneca, NICE, lynparza, ovarian cancer
AstraZeneca must provide a “robust estimate of the cost effectiveness” of its ovarian cancer treatment Lynparza, or risk being rejected …
Pharma industry worth more than $1 trillion – and growing
August 5, 2015Sales and Marketing pharma sales, research and development
Global pharmaceutical sales are set to continue rising beyond the $1 trillion milestone reached in 2014, according to newly-released figures. …
Shire goes public with rejected $30bn Baxalta bid
August 5, 2015Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease
Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …
Lilly set for Cymbalta lawsuit showdown
August 5, 2015Research and Development cymbalta, duloxetine, lawsuit, lilly
Lilly is contesting the first in a series of lawsuits brought by patients who say the company failed to inform …
First 3D-printed drug approved by FDA
August 4, 2015Manufacturing and Production, Research and Development 3d printing, FDA, manufacturing, production
The world of medicine saw a new pharma milestone this week, with the first approval by the FDA of a …
Sanofi launches new insulin Toujeo in the UK
August 4, 2015Manufacturing and Production, Sales and Marketing Lantus, Sanofi, biosimilars, diabetes, hypoglycaemia, insulin, toujeo
Sanofi’s new insulin Toujeo is now available for clinicians to prescribe in the UK. The French firm is looking to …
Hospira in major US ketorolac recall
August 4, 2015Hospira is being dogged with manufacturing problems that have led to the recall of millions of vials of its painkilling …
Teva buys majority stake in genomic analysis firm
August 4, 2015Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis
Teva has agreed to by a 51% equity share of genomic-analysis company Immuneering to advance treatments for diseases of the …
Shire in $300m Foresight acquisition
August 4, 2015Manufacturing and Production, Research and Development, Sales and Marketing FST-100, Foresight Biotherapeutics, Shire, conjunctivitis, dry eye, lifitegrast, pink eye
Shire has acquired Foresight Biotherapeutics for $300 million, as it looks to build its presence in eye diseases. The acquisition …
CSL completes $275m Novartis vaccines acquisition
August 3, 2015Manufacturing and Production, Sales and Marketing CSL, Novartis, acquisitions, asset swap, vaccines
CSL Limited has finalised its transaction to acquire Novartis’s global influenza vaccine business for $275 million. The move means Novartis …
AstraZeneca and Isis Pharma in $65m drugs collaboration
August 3, 2015Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D
Isis Pharmaceuticals and AstraZeneca have announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal …
Sir Malcolm Grant reappointed as NHS England chair
August 3, 2015Professor Sir Malcolm Grant has been re-appointed as Chair of NHS England from 31 October 2015 for a further three …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
